ANDA 88194, held by Ani Pharms. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 88194 (Thioridazine Hydrochloride), held by Ani Pharms, was first approved by FDA on Apr 14, 1983, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 14, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride50MG ยท tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Nov 7, 1986 | Supplement 17Manufacturing | Approved | None posted |
| Nov 7, 1986 | Supplement 16Manufacturing | Approved | None posted |
| Nov 7, 1986 | Supplement 15Manufacturing | Approved | None posted |
| Jun 29, 1984 | Supplement 1Manufacturing | Approved | None posted |
| Jan 17, 1984 | Supplement 5Manufacturing | Approved | None posted |
| Jan 17, 1984 | Supplement 4Manufacturing | Approved | None posted |
| Jan 17, 1984 | Supplement 3Manufacturing | Approved | None posted |
| Nov 7, 1983 | Supplement 2Manufacturing | Approved | None posted |
| Apr 14, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters